Clinical Trials on Scarring Alopecia in Finland

Total 7 results

Central Finland Hospital District
University of Eastern Finland; Tampere University Hospital

Active, not recruiting

Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting (TRUTH)

Wound Heal | Wound | Skin Wound | Skin Scarring | Wound of Skin | Wound Open | Wound Breakdown

Finland
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Alopecia Areata

Israel, China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Japan, Brazil, Argentina
Concert Pharmaceuticals

Enrolling by invitation

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
AstraZeneca
Duke Clinical Research Institute

Completed

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS)

Cost Sharing, Acute Coronary Syndrome

United States, Puerto Rico

Clinical Trials on Scarring Alopecia in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations